Cargando…

RTP4 is a novel prognosis-related hub gene in cutaneous melanoma

OBJECTIVE: Melanoma accounts for 80% of skin cancer deaths. The pathogenesis of melanoma is regulated by gene networks. Thus, we aimed here to identify gene networks and hub genes associated with melanoma and to further identify their underlying mechanisms. METHODS: GTEx (normal skin) and TCGA (mela...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yiqi, Qi, Jue, Yang, Jiankang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215788/
https://www.ncbi.nlm.nih.gov/pubmed/34154655
http://dx.doi.org/10.1186/s41065-021-00183-z
_version_ 1783710307002089472
author Li, Yiqi
Qi, Jue
Yang, Jiankang
author_facet Li, Yiqi
Qi, Jue
Yang, Jiankang
author_sort Li, Yiqi
collection PubMed
description OBJECTIVE: Melanoma accounts for 80% of skin cancer deaths. The pathogenesis of melanoma is regulated by gene networks. Thus, we aimed here to identify gene networks and hub genes associated with melanoma and to further identify their underlying mechanisms. METHODS: GTEx (normal skin) and TCGA (melanoma tumor) RNA-seq datasets were employed for this purpose. We conducted weighted gene co-expression network analysis (WGCNA) to identify key modules and hub genes associated with melanoma. Log-rank analysis and multivariate Cox model analysis were performed to identify prognosis genes, which were validated using two independent melanoma datasets. We also evaluated the correlation between prognostic gene and immune cell infiltration. RESULTS: The blue module was the most relevant for melanoma and was thus considered the key module. Intersecting genes were identified between this module and differentially expressed genes (DEGs). Finally, 72 genes were identified and verified as hub genes using the Oncomine database. Log-rank analysis and multivariate Cox model analysis identified 13 genes that were associated with the prognosis of the metastatic melanoma group, and RTP4 was validated as a prognostic gene using two independent melanoma datasets. RTP4 was not previously associated with melanoma. When we evaluated the correlation between prognostic gene and immune cell infiltration, we discovered that RTP4 was associated with immune cell infiltration. Further, RTP4 was significantly associated with genes encoding components of immune checkpoints (PDCD1, TIM-3, and LAG3). CONCLUSIONS: RTP4 is a novel prognosis-related hub gene in cutaneous melanoma. The novel gene RTP4 identified here will facilitate the exploration of the molecular mechanism of the pathogenesis and progression of melanoma and the discovery of potential new target for drug therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41065-021-00183-z.
format Online
Article
Text
id pubmed-8215788
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82157882021-06-23 RTP4 is a novel prognosis-related hub gene in cutaneous melanoma Li, Yiqi Qi, Jue Yang, Jiankang Hereditas Research OBJECTIVE: Melanoma accounts for 80% of skin cancer deaths. The pathogenesis of melanoma is regulated by gene networks. Thus, we aimed here to identify gene networks and hub genes associated with melanoma and to further identify their underlying mechanisms. METHODS: GTEx (normal skin) and TCGA (melanoma tumor) RNA-seq datasets were employed for this purpose. We conducted weighted gene co-expression network analysis (WGCNA) to identify key modules and hub genes associated with melanoma. Log-rank analysis and multivariate Cox model analysis were performed to identify prognosis genes, which were validated using two independent melanoma datasets. We also evaluated the correlation between prognostic gene and immune cell infiltration. RESULTS: The blue module was the most relevant for melanoma and was thus considered the key module. Intersecting genes were identified between this module and differentially expressed genes (DEGs). Finally, 72 genes were identified and verified as hub genes using the Oncomine database. Log-rank analysis and multivariate Cox model analysis identified 13 genes that were associated with the prognosis of the metastatic melanoma group, and RTP4 was validated as a prognostic gene using two independent melanoma datasets. RTP4 was not previously associated with melanoma. When we evaluated the correlation between prognostic gene and immune cell infiltration, we discovered that RTP4 was associated with immune cell infiltration. Further, RTP4 was significantly associated with genes encoding components of immune checkpoints (PDCD1, TIM-3, and LAG3). CONCLUSIONS: RTP4 is a novel prognosis-related hub gene in cutaneous melanoma. The novel gene RTP4 identified here will facilitate the exploration of the molecular mechanism of the pathogenesis and progression of melanoma and the discovery of potential new target for drug therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41065-021-00183-z. BioMed Central 2021-06-21 /pmc/articles/PMC8215788/ /pubmed/34154655 http://dx.doi.org/10.1186/s41065-021-00183-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Yiqi
Qi, Jue
Yang, Jiankang
RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
title RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
title_full RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
title_fullStr RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
title_full_unstemmed RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
title_short RTP4 is a novel prognosis-related hub gene in cutaneous melanoma
title_sort rtp4 is a novel prognosis-related hub gene in cutaneous melanoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215788/
https://www.ncbi.nlm.nih.gov/pubmed/34154655
http://dx.doi.org/10.1186/s41065-021-00183-z
work_keys_str_mv AT liyiqi rtp4isanovelprognosisrelatedhubgeneincutaneousmelanoma
AT qijue rtp4isanovelprognosisrelatedhubgeneincutaneousmelanoma
AT yangjiankang rtp4isanovelprognosisrelatedhubgeneincutaneousmelanoma